Research

Hormonal

Weekly subcutaneous administration of GLP-1 receptor agonist (dulaglutide) significantly reduces HbA1c and body weight in patients with Type 2 Diabetes Mellitus who fail to adhere to low carbohydrate diet (LCD) or calorie restriction diet (CRD).

If you have Type 2 Diabetes and struggle to maintain a low-carb or calorie-restricted diet due to lifestyle, cognitive issues, or lack of support, ask your doctor about once-weekly GLP-1 receptor agonists like dulaglutide. This medication can significantly lower blood sugar (HbA1c) and help with weight loss even when dietary adherence is inconsistent. It is particularly useful for elderly patients or those with comorbidities who find daily management difficult.

LimitedSupportsMEDIUM confidence
Among them, we report and discuss here from various points of view... As a result, weight reduction and decreased HbA1c were found except for case-4... There was a tendency of weight reduction and decreased HbA1c value in 3 months.
Masahiro Shirakawa et al. · Asploro Journal of Biomedical and Clinical Case Reports · 2019

Why this rating

Small case series (n=7) without a control group; results are observational within a clinical setting.

Source

Diabetic cases controlled with low carbohydrate diet (LCD) and GLP-1 receptor agonist (GLP-1 RA)

Masahiro Shirakawa et al. · Asploro Journal of Biomedical and Clinical Case Reports · 2019

DOI 10.36502/2019/asjbccr.6137

case_series · n=7
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →